Riya Negi

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report.

Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 23, 2025

Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final report.

Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final report.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 23, 2025

Associations Between the Gut Microbiome, Inflammation, and Cardiovascular Profiles in People With Human Immunodeficiency Virus.

Associations Between the Gut Microbiome, Inflammation, and Cardiovascular Profiles in People With Human Immunodeficiency Virus.

Journal: The Journal of infectious diseases

Published: November 07, 2024

Associations between type III interferons, obesity and clinical severity of COVID-19.

Associations between type III interferons, obesity and clinical severity of COVID-19.

Journal: Frontiers in immunology

Published: October 24, 2024

Longitudinal SARS-CoV-2 antibody response in a healthcare worker cohort utilising the Abbott Alinity® anti-nucleocapsid assay.

Longitudinal SARS-CoV-2 antibody response in a healthcare worker cohort utilising the Abbott Alinity® anti-nucleocapsid assay.

Journal: PloS one

Published: April 01, 2024

Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B).

Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B).

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 27, 2024

Early inflammatory profiles predict maximal disease severity in COVID-19: An unsupervised cluster analysis.

Early inflammatory profiles predict maximal disease severity in COVID-19: An unsupervised cluster analysis.

Journal: Heliyon

Published: March 14, 2024

Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).

Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).

Journal: Vaccine

Published: June 04, 2023

Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severity.

Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severity.

Journal: Microbes and infection

Published: April 12, 2023

Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time.

Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time.

Journal: Nature communications

Published: August 10, 2022

Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination.

Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination.

Journal: Journal of immunological methods

Published: April 27, 2022

Biomarker associations with insomnia and secondary sleep outcomes in persons with and without HIV in the POPPY-Sleep substudy: a cohort study.

Biomarker associations with insomnia and secondary sleep outcomes in persons with and without HIV in the POPPY-Sleep substudy: a cohort study.

Journal: Sleep

Published: April 08, 2022

Showing 1-12 of 12

Last Updated: 09/26/2026